RxSight files $200M shelf registration and enters $50M ATM equity offering with BofA

RxSight, Inc.

Filed $200M shelf registration on Form S-3 covering common stock, preferred, debt, warrants, and units.
Entered ATM agreement to sell up to $50M of common stock through BofA Securities.
Registration statement is not yet effective; no sales can occur until SEC declares it effective.
BofA will receive 3% commission on gross proceeds from ATM sales; Company may also sell directly to BofA as principal.
Either party may terminate the ATM agreement with three days' written notice.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.